Clinical approach and utilizing liquid biopsies to interrogate suspected acquired resistance to PD-1 blockade
PD-1 blockade is now routine for nearly all patients with non-small lung cancer. Acquired resistance to PD-1 blockade – defined generally as an initial response followed later by progression [1-3] is a common yet poorly understood concept. A key clinical challenge to insight has been a lack of stand...
Saved in:
Main Authors: | Dilanka Lakshan De Silva, Jia Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Future Science OA |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.2144/fsoa-2023-0010 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exosomal PD-L1 detection in cancer predictive biomarker for response to immune checkpoint blockade therapy
by: Tetsuichi Kansha, et al.
Published: (2025-07-01) -
Cancer therapeutic implications of microRNAs in the regulation of immune checkpoint blockade
by: Yan Zhang, et al.
Published: (2019-08-01) -
Leveraging liquid biopsy to uncover resistance mechanisms and guide personalized immunotherapy
by: Zeinab Dalloul, et al.
Published: (2025-09-01) -
PD-L1 as a Potential Target in Cancer Therapy (Review)
by: N. N. Andrusova, et al.
Published: (2021-02-01) -
MONITORING OF VARIOUS TYPES OF NEUROMUSCULAR BLOCKADE
by: N. V. Chubchenko, et al.
Published: (2018-01-01)